509 related articles for article (PubMed ID: 11147804)
21. A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity.
Janulis M; Trakul N; Greene G; Schaefer EM; Lee JD; Rosner MR
Mol Cell Biol; 2001 Mar; 21(6):2235-47. PubMed ID: 11238956
[TBL] [Abstract][Full Text] [Related]
22. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
24. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.
Adi S; Bin-Abbas B; Wu NY; Rosenthal SM
Endocrinology; 2002 Feb; 143(2):511-6. PubMed ID: 11796505
[TBL] [Abstract][Full Text] [Related]
25. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
26. P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway.
Tu MT; Luo SF; Wang CC; Chien CS; Chiu CT; Lin CC; Yang CM
Br J Pharmacol; 2000 Apr; 129(7):1481-9. PubMed ID: 10742305
[TBL] [Abstract][Full Text] [Related]
27. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
Rommel C; Clarke BA; Zimmermann S; Nuñez L; Rossman R; Reid K; Moelling K; Yancopoulos GD; Glass DJ
Science; 1999 Nov; 286(5445):1738-41. PubMed ID: 10576741
[TBL] [Abstract][Full Text] [Related]
28. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Silvany RE; Eliazer S; Wolff NC; Ilaria RL
Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
[TBL] [Abstract][Full Text] [Related]
29. Proliferation of IL-6-independent multiple myeloma does not require the activity of extracellular signal-regulated kinases (ERK1/2).
Zhang B; Fenton RG
J Cell Physiol; 2002 Oct; 193(1):42-54. PubMed ID: 12209879
[TBL] [Abstract][Full Text] [Related]
30. Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1).
Shapiro PS; Ahn NG
J Biol Chem; 1998 Jan; 273(3):1788-93. PubMed ID: 9430728
[TBL] [Abstract][Full Text] [Related]
31. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.
Hochholdinger F; Baier G; Nogalo A; Bauer B; Grunicke HH; Uberall F
Mol Cell Biol; 1999 Dec; 19(12):8052-65. PubMed ID: 10567531
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
33. The role of MKK1/2 kinase activity in human cytomegalovirus infection.
Johnson RA; Ma XL; Yurochko AD; Huang ES
J Gen Virol; 2001 Mar; 82(Pt 3):493-497. PubMed ID: 11172089
[TBL] [Abstract][Full Text] [Related]
34. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
[TBL] [Abstract][Full Text] [Related]
36. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
Yan F; Polk DB
Cancer Res; 2001 Feb; 61(3):963-9. PubMed ID: 11221891
[TBL] [Abstract][Full Text] [Related]
37. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation.
Maher P
J Biol Chem; 1999 Jun; 274(25):17491-8. PubMed ID: 10364180
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of pentalenolactone on vascular smooth muscle cell proliferation.
Ikeda M; Fukuda A; Takagi M; Morita M; Shimada Y
Eur J Pharmacol; 2001 Jan; 411(1-2):45-53. PubMed ID: 11137857
[TBL] [Abstract][Full Text] [Related]
39. HSP25 overexpression attenuates oxidative stress-induced apoptosis: roles of ERK1/2 signaling and manganese superoxide dismutase.
Lee YJ; Cho HN; Jeoung DI; Soh JW; Cho CK; Bae S; Chung HY; Lee SJ; Lee YS
Free Radic Biol Med; 2004 Feb; 36(4):429-44. PubMed ID: 14975446
[TBL] [Abstract][Full Text] [Related]
40. ERK activation and mitogenesis in human airway smooth muscle cells.
Lee JH; Johnson PR; Roth M; Hunt NH; Black JL
Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L1019-29. PubMed ID: 11290527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
